New research has identified some factors that may lead to some skin cancers no longer responding to treatment. Published in Cancer...

Risankizumab has been shown to be efficacious and safe in patients with plaque psoriasis who have a suboptimal response to IL-17 inhibitors.

An anonymous, voluntary survey of 359 patients showed most considered having access to their medical records as a favourable development....

A group of researchers from Japan have developed a new model for the estimation of trans-epidermal water loss (TEWL) without the need for...

Sleep disturbances in adults with moderate-to-severe AD generally improve over time.

The Chronicle of Skin & Allergy, in partnership with the Dermatology Industry Taskforce on Inclusion, Diversity and Equity (DiTiDE),...

In a recent clinical trial, a combination of methotrexate and low-dose prednisone led to complete hair regrowth (HR) in almost one-third...

New findings show that AD incidence and prevalence have increased over the last two decades, especially in Black and multiracial children.